Related Experiment Video
Updated: Jan 8, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Bone health in an upper Midwestern health system: Years 2008-2015
Ana M Fernandez1, Claudia C Ramjattan2, Colleen M Renier2
1Essentia Health - St. Mary's Duluth Clinic, 400 E 3rd St, Duluth, MN, 55805, USA.
Introduction:
Osteoporosis, osteopenia, and low impact fractures have documented effects on morbidity and mortality. This study explores the prevalence of osteoporosis and osteopenia among United States patients referred for a DXA scan and profiles patients experiencing low impact hip fractures (LIHFs) in an Upper Midwestern program to improve treatment and prevent secondary fractures in these patients.
Methodology:
This retrospective observational study analyzed data from an in-house osteoporosis program database, trauma registry, and electronic health records. A DXA scan cohort included patients aged ≥50 years with completed DXA scans from 1/1/2008-9/30/2015. A LIHF cohort included patients aged ≥65 years receiving LIHF care from 1/1/2008-6/30/2015. Analyses included descriptive statistics, binary logit-linked generalized estimating equations, and survival analyses comparing mortality outcomes.
Results:
In total, 11,725 patients received a DXA scan during the study period, of whom 21.3 % had osteoporosis and 33.9 % had osteopenia. Of those with osteoporosis, 46.3 % were on osteoporosis medication six months after a DXA scan. Mortality rates were low in the DXA scan cohort. Of 1207 patients aged ≥65 years with LIHFs, 12.8 % received osteoporosis medication six months following the LIHF. The one-year mortality rate post-LIHF was 29.6 % across females and males. Mortality odds and hazards were significantly lower in those with DXA scans versus those with no DXA scan documented.
Conclusions:
Opportunities to improve bone health management are achievable by enhancing recognition and treatment of patients at high risk for LIHFs, including those without prior DXA scans. Ongoing collaborative care supporting initiation of medication treatment following LIHFs is necessary.
More Related Videos
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
09:02Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...